ISIS 721744 clinical trials

ISIS 721744-CS3: An Open-Label Extension Study of ISIS 721744 in Patients with Hereditary Angioedema

This study is looking at a new medicine called ISIS 721744 for people with Hereditary Angioedema (HAE). It's an extension of an earlier study, gathering more information on its safety and how well it helps reduce HAE attacks and improve quality of life.